The application relates to a preparation method of MMP-13 response nanoparticles loaded with PDRN, and belongs to the technical field of biological medicines. In order to solve the problems of low transdermal efficiency of polydeoxyribonucleotide, poor stability under conventional storage conditions, and the fact that a traditional
delivery system cannot distinguish between aging and normal tissues, leading to insufficient concentration at a
target site and low
bioavailability, the application provides MMP-13 response nanoparticles loaded with PDRN. By introducing a natural and safe response unit and a cross-linking strategy, an innovative full-chain solution and
solid data support are provided for the development of the next generation of intelligent anti-aging
cosmetics which are precise in targeting, efficient in anti-aging, and excellent in stability.